Midazolam Injection, Solution
Product Images NDC 82449-209

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 82449-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Steriscience Specialties Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-06 (Image 06)

Image-06 (Image 06)
Midazolam Injection USP 25 mg per 5 mL (5 mg per mL) sterile solution in a 5 mL multi-dose vial. The label indicates the product is for intravenous or intramuscular use, containing midazolam hydrochloride equivalent to 5 mg per mL. Manufactured for Sagent Pharmaceuticals, made in India, with storage instructions at controlled room temperature (20° to 25°C).*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Image 4)

Package Label – Principal Display Panel – Vial Label (Image 4)
Midazolam Injection, USP 10 mg per 10 mL (1 mg per mL) multi-dose vial label by Sagent Pharmaceuticals. The sterile injectable solution is for intravenous or intramuscular use. The label includes NDC 25021-660-10 and manufacturer details indicating it is made in India and distributed by Sagent Pharmaceuticals, Schaumburg, IL.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Image 5)

Package Label – Principal Display Panel – Vial Label (Image 5)
Label for Midazolam Injection, USP 5 mg/mL, shown as 25 mg per 5 mL in a multi-dose vial. The sterile injectable solution is for intravenous or intramuscular use. The label indicates the product is manufactured for Sagent Pharmaceuticals by Steriscience Specialties Private Limited in India. Storage instructions specify 20 to 25°C (68 to 77°F).*
FDA Label Image

Structural Formula (Img 1)

Structural Formula (Img 1)
Chemical structure of midazolam hydrochloride, showing its molecular framework with ring systems and functional groups including chlorine and fluorine atoms.*
FDA Label Image

Midazolam (Img 2)

Midazolam (Img 2)
Chemical structure diagram showing two forms of the active ingredient midazolam hydrochloride: the closed-ring form labeled "Midazolam" and the open-ring form labeled "Open-ring Form." These alternate structures depict the molecule's reversible ring opening.*
FDA Label Image

Img-3 (Img 3)

Img-3 (Img 3)
A line graph illustrating the pH dependence of the open-ring form of a substance in water. The x-axis represents pH values ranging from 2.5 to 5.5, and the y-axis shows the percentage of the open-ring form, which decreases sharply from about 50% at pH 2.5 to near 0% by pH 5.5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.